CAS: 32385-58-3 - Carbamimidothioic acid, 2-(1H-imidazol-5-yl)ethyl ester, hydrobromide (1:2)
Fórmula:C6H10N4S·2BrH
InChI:InChI=1S/C6H10N4S.2BrH/c7-6(8)11-2-1-5-3-9-4-10-5;;/h3-4H,1-2H2,(H3,7,8)(H,9,10);2*1H
Clave InChI:InChIKey=DOBOYMKCRRLTRF-UHFFFAOYSA-N
SMILES:Br.N=C(SCCC1=CN=CN1)N
- Sinónimos:
- 2-(1H-Imidazol-4-yl)ethyl carbamimidothioate dihydrobromide
- Carbamimidothioic acid, 2-(1H-imidazol-4-yl)ethyl ester, dihydrobromide
- Carbamimidothioic acid, 2-(1H-imidazol-4-yl)ethyl ester, hydrobromide (1:2)
- Carbamimidothioic acid, 2-(1H-imidazol-5-yl)ethyl ester, hydrobromide (1:2)
- Imetit dihydrobromide
- Pseudourea, 2-(2-imidazol-4-ylethyl)-2-thio-, dihydrobromide
- S-[2-(4(5)-Imidazolyl)ethyl]isothiourea dihydrobromide
Imetit dihydrobromide, 98%
CAS:32385-58-3
An extremely potent, high affinity agonist at H3 and H4 receptors This Thermo Scientific Chemicals …
Fórmula:
C6H10N4S•2HBr
Pureza:
98%
Forma y color:
Powder, Off-white to yellow to brown
Peso molecular:
332.06
Ref: 02-J62346
50mg | 374,00 € | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 2 de Enero de 2025
Ref: IN-DA00C5P4
10mg | 197,00 € | ||
25mg | 567,00 € | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 8 de Enero de 2025
Ref: 7W-GL8474
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Jueves 9 de Enero de 2025
Imetit dihydrobromide
CAS:32385-58-3
Agonist of H3 and H4 receptors
Fórmula:
C6H10N4S·2HBr
Pureza:
Min. 95%
Forma y color:
Powder
Peso molecular:
332.06 g/mol
Ref: 3D-FI02575
10mg | 184,00 € | ||
25mg | 381,00 € | ||
50mg | 539,00 € | ||
100mg | 828,00 € | ||
250mg | 1.620,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
Imetit dihydrobromide
CAS:32385-58-3
Imetit dihydrobromide is a high affinity and effective agonist of histamine H3 and H4 receptors …
Fórmula:
C6H12Br2N4S
Pureza:
98%
Forma y color:
Solid
Peso molecular:
332.06
Ref: TM-T15565
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 26 de Febrero de 2025